Xiaoyan Yu

ORCID: 0000-0003-0351-8393 · 3 papers in corpus
review 2026
Frontiers in microbiology ·doi:10.3389/fmicb.2026.1795152

Sex hormone related disorders, characterized by complex etiology and long-term health risks, pose a significant challenge to global health. Hormone-based therapies are often accompanied by adverse effects and fail to address the underlying …

article 2025
·doi:10.2147/jir.s530521

Background: Pelvic inflammatory disease (PID) is a common gynecological disorder that seriously affects women's physical and mental health, yet there are few effective therapeutic options. Objective: Mendelian randomization (MR) has been us…

article 2021
Acta histochemica ·doi:10.1016/j.acthis.2021.151749

Previous studies report that fibroblast growth factor 2 (FGF2) modulates Sproutys (SPRYs)/dual specificity phosphatase 6 (DUSP6)/extracellular signal-regulated kinase (ERK) signaling pathway in endometrial glandular epithelial cells. Howeve…